University of Tennessee Health Science Center
Memphis, Tennessee, 38103, United States
Location status: Recruiting
NCT Number: NCT06532708
The purpose of this study is to compare opioid prescribing practices by either routine provider prescribing practices, or with the use of a calculator, i.e., the Opioid Calculator, published by the University of Michigan (www.opioidcalculator.org), with the intent of decreasing the number of pills.
Interested in participating?
Request Info18 year–80 year
Female
Interventional
Not applicable
Memphis, Tennessee, 38103, United States
Location status: Recruiting
The intent of this study is to validate the use of the Opioid Calculator, published at University of Michigan (www.opioidcalculator.org), which takes several variables into account, including age, risk factors (history of depression, alcohol abuse, others) to determine in a more scientific way the number of pills sufficient to prescribe. The sample size was determined by the number of routine post-op laparoscopic patients seen in our practice. The estimated necessary sample size is 6 participants per group (12 total). Patients will be randomized using 3 block groups of size 4 each. Patients will be approached at in clinic at the time they are consenting to laparoscopic hysterectomy and will be counseled about postoperative pain medication management. Randomization to either standard practice or calculator will be performed using computer-generated, permuted blocks of 4 participants. Sealed randomization envelopes will be opened for each subject on the day of surgery, after anesthesia is initiated. The study will be singled-blinded to the participant. Patients will be contacted on day 2 and day 7 to inquire where they are on the Visual Analog Scale (VAS) and how many pills they have taken. Two weeks after surgery patients will be seen in office for VAS and requested to bring unused pills for accounting purposes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be prescribed 5 doses of 5mg tablets of oxycodone for postoperative pain relief.
Participants will be prescribed 16 doses of 5mg tablets of oxycodone for postoperative pain relief.
Time frame: Within 1 week following surgery
All participants will be contacted on postoperative days 2 and 7 to inquire how many pills they have taken
Time frame: Within 2 weeks following surgery
All participants will be contacted on postoperative days 2 and 7, and at their two-week follow-up visit to inquire where their pain level is on the Visual Analog Scale (VAS). This scale ranges from 0 to 10, with 0 indicating no pain and 10 indicating worst possible pain.
Interested in participating?
Request InfoUniversity of Tennessee
Other
Prospective Study of Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07674836
Neurologic Manifestations, Opioid Use
İzmit, Kocaeli, Turkey (Türkiye)
View Trial DetailsNCT06023225
Neurologic Manifestations, Opioid Use
St Louis, Missouri, United States
View Trial DetailsNCT04894864
Abdominal Aortic Aneurysm Without Rupture, Anesthesia
Heraklion, Crete, Greece
View Trial DetailsNCT03675386
Chemically-Induced Disorders, Chronic Pain
Toronto, Ontario, Canada
View Trial Details